RC88-ADC

· RemeGen Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RC88-ADC, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors [Phase 1, Phase 2]